Learn More
BACKGROUND Adalimumab is efficacious therapy for adults with Crohn's disease (CD). AIM To summarise the United Kingdom and Republic of Ireland paediatric adalimumab experience. METHODS British(More)
BACKGROUND Exclusive enteral nutrition (EEN) achieves variable remission rates in patients with Crohn's disease (CD). AIM To describe our experience of treating CD with an 8-week course of primary(More)